Ambrx

Ambrx is a biopharmaceutical company that discovers and develops engineered precision biologics therapeutics using an expanded genetic code. Its pipeline is focused on creating antibody-drug conjugate and immune-oncology conjugate candidates. The company develops the treatment of breast cancer, gastric/gastroesophageal junction (GEJ) cancer, and other solid tumors.